Tetsuya Okano
- Bevacizumab shows survival benefit for non-small lung cancer patients who received subsequent pemetrexed treatment but not had a therapeutic effect in clinical practiceBy Nobuyuki Koyama, Shohei Minesaki, Susumu Yamazaki, Harue Utsugi, Yuri Maeno, Tetsuya Okano, Yoshitake Murayama and Kunihiko KobayashiNobuyuki Koyama1Respiratory Medicine, Saitama Medical University International Medical Center, Hidaka-shi, Saitama, JapanShohei Minesaki1Respiratory Medicine, Saitama Medical University International Medical Center, Hidaka-shi, Saitama, JapanSusumu Yamazaki1Respiratory Medicine, Saitama Medical University International Medical Center, Hidaka-shi, Saitama, JapanHarue Utsugi1Respiratory Medicine, Saitama Medical University International Medical Center, Hidaka-shi, Saitama, JapanYuri Maeno1Respiratory Medicine, Saitama Medical University International Medical Center, Hidaka-shi, Saitama, JapanTetsuya Okano1Respiratory Medicine, Saitama Medical University International Medical Center, Hidaka-shi, Saitama, JapanYoshitake Murayama1Respiratory Medicine, Saitama Medical University International Medical Center, Hidaka-shi, Saitama, JapanKunihiko Kobayashi1Respiratory Medicine, Saitama Medical University International Medical Center, Hidaka-shi, Saitama, Japan
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.